• Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

A Dilemma for Governments: How to Pay for Million-Dollar Therapies

The New York Times – Business:

A wave of transformative but hugely expensive treatments is challenging the budgets of health systems in wealthy nations. Now countries with far fewer resources are wrestling with how to cover the therapies.

Rebecca Robbins
Author: Rebecca Robbins

This post first appeared in The New York Times – Business. Read the original article.

Written by

Rebecca Robbins

in

Brazil, Children and Childhood, Disabilities, Drugs (Pharmaceuticals), Genetic Engineering, Genetics and Heredity, Medicine and Health, Novartis AG, Spinal Muscular Atrophy, Suits and Litigation (Civil)
←Long Covid Is Keeping Significant Numbers of People Out of Work, Study Finds
Judge To Hold Hearing Over Georgia Special Grand Jury Report→

More posts

  • Spotify once had a reputation for underpaying music artists. It hopes to change that perception

  • How Trump and His Advisers Miscalculated Iran’s Response to War

  • Mickey Rourke evicted over $60,000 in unpaid rent after turning down $100,000 in donations

  • Georgia special election to replace Marjorie Taylor Greene headed to runoff

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube